Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC Health Industries Vice Chair, Jenny Colapietro, in discussion with US Pharmaceutical & Life Sciences Deals Leader, Glenn Hunzinger and US Health Services Deals Leader, Nick Donkar, on current deal trends impacting the health sector. This episode includes:

• Significant mergers and acquisitions of 2021
• Future deal drivers for 2022 and the potential impact on current trends
• Deal growth activity in healthcare and pharma & life sciences subsectors

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC Health Industries Vice Chair, Jenny Colapietro, in discussion with the Founder & CEO of Concert Health, Spencer Hutchins, on the evidence-based health care model that will help tighten the gaps in our behavioral and mental health services. This episode includes:

• How Concert Health’s collaborative care model addresses issues around healthcare access and integration
• The importance of integration and partnerships with providers and payors in addressing behavioral health
• Leveraging data and analytics to drive growth and innovation in behavioral health services
• Key considerations to reduce racial disparities and prevent burnout in behavioral health care

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Principal, Omar Chane, and PwC Managing Director, Amy Hunckler, on the evolution of the vaccines market and mRNA technology, including:

• The impact of new entrants on the vaccine industry
• Manufacturers' role in improving the customer experience
• How mRNA and its various applications will continue to shape the pharmaceutical and life sciences industry

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC's Pharmaceutical and Life Sciences Research and Development Principals, Anup Kharode and Brian Slizgi, on the evolution of the clinical trial delivery model, including:

• Impact of COVID-19 on clinical trials and research
• Emerging trends and disruptors
• Implications for clinical research organizations (CROs) and the broader pharmaceutical industry
• The future of decentralized clinical trials

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Director, James Lin, on price transparency regulations, including:

• Key implications and considerations for payers, providers and pharma and life sciences
• Impacts to consumer behavior and market pricing
• How to improve the relationship between price and quality transparency.

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC’s Consulting Solutions Director, Aparna Kumar, on how the next generation is transforming philanthropy to drive organizational success and social change, including:

• The current philanthropic funding landscape
• Benefits of strategic partnerships
• The role of technology in shaping the future of philanthropy
• Bridging the relationship between philanthropy and ESG

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Principal, Kevin McLellan, on the latest medical device trends and innovations, including:

• Shifting consumer and patient engagement
• Implications of connected devices and data on care experience
• Differentiated growth opportunities for medical technology to unlock value and reimagine tradition care model

Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC Principal, Paul Leinwand, PwC Director, Inshita Wij and PwC Senior Manager, Lauren Christian, on recent consumer healthcare survey findings, including:

• What consumers are seeking from their healthcare experience and how health systems can respond
• Must-haves for improving consumer experience and loyalty
• The demand for virtual care persists
• Future considerations for health organizations to increase consumer engagement

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC’s Partner, Derek Gaasch, on how health insurance companies can optimize their member engagement, to help them achieve better health, including:

• The consumerization of health
• The importance of advocacy for members and health insurers
• Proactive efforts to increase members’ health and wellness engagement
• Technology’s impact on member advocacy

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with PwC’s Consulting Solutions Director, Aparna Kumar, on how the U.S. can overcome the shortage of healthcare workers, including:

• Physician workforce projections released in The Association of American Medical Colleges’ (AAMC) annual report
• The pandemic’s impact on the physician shortages
• Decreasing regulatory barriers for internationally educated physicians could ease the burden of physician shortages
• Short-term strategies to address physician workforce shortages

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with US Pharmaceutical & Life Sciences Deals Leader, Glenn Hunzinger and US Health Services Deals Leader, Nick Donkar, on the current deals activity impacting the health and pharma and life sciences sectors, including: 

• Tailwinds that are driving sector deals activity and growth
• Headwinds that pose challenges for deals activity
• Factors that can influence merger and acquisition success
• Deals landscape outlook 

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with Pharmaceutical Quality Partner, Jan Paul Zonnenberg, on the importance of drug quality in the health ecosystem, including:

• The history and current state of pharmaceutical quality in the U.S.
• Patient trust and quality in the drug development ecosystem
• What forces are accelerating quality improvements?
• The role of culture in improving drug quality

Tune into this episode of PwC's Next in Health to hear PwC US Healthcare Technology Consulting Leader Will Perry, in discussion with Microsoft’s Chief Medical Officer, Dr. David Rhew, on how technology is fundamentally changing how healthcare is designed and delivered, including:

• What role does Microsoft play in the health ecosystem?
• The importance of digital channels and engagement
• Consumer digital health journey
• Predictive analytics and the future of healthcare

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, discuss medical cost trend for 2021 and expectations for 2022, including:

• The impact of COVID-19
• Projections for the coming year
• The effects of deferred care and intervention
• The need for investments in forecasting and predictive modeling

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, and Strategy& Principal, Igor Belokrinitsky, in discussion with Health Industries Principal, Abbas Mooraj, on how cloud enables healthcare organizations to harness data and analytics, including:

• Current cloud-based investments for providers
• Future of the healthcare system’s cloud journey
• Enterprise cloud computing’s return on investment
• Leveraging cloud technologies to adopt a more patient-centric healthcare system

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Trine Tsouderos, in discussion with PwC’s Health Services Principal, Claudia Douglass, on the future of telehealth in a post COVID-19 world, including:

• The current state of telehealth
• Different types of telehealth services
• Connected diagnostic devices and technical infrastructure requirements
• Designing a more consumer-centric telehealth experience

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Benjamin Isgur and Trine Tsouderos, in discussion with PwC’s HIA Operations Strategy Principal, Namit Mehta and PwC's Cyber Security Principal, Robbie Higgins, on how organizations can build resiliency and plan for future potential supply chain disruptions, including:

• Importance of scenario planning in building resiliency
• Organizational interventions to consider and/or prioritize to secure the supply chain
• Steps for organizations to take to begin scenario planning
• Future technologies and their impact on the future health system

Tune into this episode of PwC's Next in Health to hear PwC Health Research Institute's Benjamin Isgur and Trine Tsouderos in discussion with PwC’s Strategy& Partner, Will Nolen, on why quality improvement in healthcare is important, including:

• The differing definitions of healthcare quality among stakeholders and consumers across the ecosystem
• The association between healthcare quality and costs
• The importance of designing more consumer centric quality offerings through technology and innovation
• The significance of archetypes in the quality of healthcare

Tune into this episode of PwC's Next in Health to hear Health Research Institute leader, Benjamin Isgur, and Health Research Institute Regulatory Center leader, Trine Tsouderos in discussion with PwC’s Deals Strategy & Pharma and Life Sciences Principal, Claire Love, on what role private equity firms play, in the rapid growth market of gene and cell therapies, including:

• What are the growth drivers for private equity firms?
• What technologies and innovations can be leveraged to increase supply chain efficiency?
• Opportunities and risks private equity firms should consider
• Improving collaboration between the pharmaceutical industry and private equity investors

PwC research and insights on the private exchange value proposition, and the evolution of private exchanges

Results from the Private Exchange Evaluation Collaborative's survey, based on the responses of 446 employers, regarding private exchanges as a strategy for full-time active and retirees, and a national assessment that specifically captures the experience of early adopters of both private exchanges for active employees as well as retirees.

Sessions include: Top Health Industry Issues for 2015; Key Healthcare Legal, Regulatory and Policy Issues for 2015; and ICD-10 as a Strategic Enabler in 2015.

PwC research, insights and perspectives regarding the continued evolution towards private exchanges including defined contribution approaches.

This session presents detailed findings and analysis of PwC's 2011 HIX report, Change the channel: Health insurance exchanges expand choice and competition. It outlines the key strategic considerations for insurers as they gear up for participation in health insurance exchanges, including the impact of various exchange models on their business. Each state has flexibility in how to design and operate an exchange, which could mean dozens of variations in exchange models across the country. The differences could make some exchanges profitable for some insurers but not for others, and insurers will need to decide which ones they will enter. Join PwC's Serena Foong and Shannon Smith as they discuss PwC's HIX report in depth, address strategic considerations for stakeholders, and tackle your specific HIX questions.